{"id":384229,"date":"2020-11-18T11:09:15","date_gmt":"2020-11-18T16:09:15","guid":{"rendered":"http:\/\/www.marketnewsdesk.com\/?p=384229"},"modified":"2020-11-18T11:09:15","modified_gmt":"2020-11-18T16:09:15","slug":"nxtc-investor-filing-deadline-bernstein-liebhard-reminds-investors-of-the-deadline-to-file-a-lead-plaintiff-motion-in-a-securities-class-action-lawsuit-against-nextcure-inc-7","status":"publish","type":"post","link":"https:\/\/www.marketnewsdesk.com\/index.php\/nxtc-investor-filing-deadline-bernstein-liebhard-reminds-investors-of-the-deadline-to-file-a-lead-plaintiff-motion-in-a-securities-class-action-lawsuit-against-nextcure-inc-7\/","title":{"rendered":"NXTC INVESTOR FILING DEADLINE: Bernstein Liebhard Reminds Investors of the Deadline to File a Lead Plaintiff Motion in a Securities Class Action Lawsuit Against NextCure Inc."},"content":{"rendered":"<div class=\"mw_release\">\n<p>NEW YORK, Nov.  18, 2020  (GLOBE NEWSWIRE) &#8212; Bernstein Liebhard, a nationally acclaimed investor rights law firm, reminds investors of the deadline to file a lead plaintiff motion in a securities class action that has been filed on behalf of investors that: (i) purchased or acquired the securities of NextCure, Inc. (\u201cNextCure\u201d or the \u201cCompany\u201d) (NASDAQ: NXTC) securities between November 5, 2019 to July 14, 2020; and (ii) purchased or acquired NextCure common stock pursuant to or traceable to the Company&#8217;s Registration Statement on Form S-1 which was filed with and declared effective by the SEC on November 12, and November 14, 2019. The lawsuit filed in the United States District Court for the Southern District of New York alleges violations of the Securities Act of 1933 and the Securities Exchange Act of 1934.<\/p>\n<p>If you <strong>purchased <\/strong><strong>NextCure<\/strong><strong> securities, and\/or would like to discuss your legal rights and options<\/strong> please visit <a href=\"https:\/\/www.globenewswire.com\/Tracker?data=bIguIbFCIUBMTNaNz3rbEB0n_ncTAQAs8ZVNYRAN1HSxwUgzG2GOb8qhks3ucB5LBkzgctRubSEEelQBhJ0XW5-0V7tdVyytEBcLODC8ssYoVgG2V5VKl9DvOvwGLSLCb18f4gL3byzruy_zkCiyaJ3W21vsoc_nLBfnVV74qPbfjWxvMd9S6-NvZ8Eaxn8bIYm5LiIqZFkrvrvZx-CJJuACdpnkFa2Jy6ux3fe-pgk=\" rel=\"nofollow noopener noreferrer\" target=\"_blank\">NXTC Shareholder Class Action Lawsuit<\/a> or contact <a href=\"https:\/\/www.globenewswire.com\/Tracker?data=QE4xSYFeDqWAbaLeuAJ8eALsKYGvQWjaNGGoLnUF1jxhsK8v5iPQWEF52NhGSVbgLQXDNYe5JKyvV_nSO5YCq7Dmx9lJOh0TwxaUladQiKM=\" rel=\"nofollow noopener noreferrer\" target=\"_blank\">Matthew E. Guarnero<\/a> toll free at <strong>(877) 779-1414<\/strong> or <a href=\"https:\/\/www.globenewswire.com\/Tracker?data=U3XY2jaO9rXoljJphjpATGMjKzccvKxPp-9Gm8RcD_i35uOYvGPtSdyPZkDg2GuyaFskS4gaDHJVxLmXhEIzJD_2rtQwQCjfzVVU24_crzE=\" rel=\"nofollow noopener noreferrer\" target=\"_blank\">MGuarnero@bernlieb.com<\/a>.<\/p>\n<p>Throughout the Class Period, Defendants misled investors regarding its leading treatment candidate, NC318, which was a first-in-class immunomedicine targeting a novel immunomodulatory receptor, called Siglec-15, or S15, particularly in patients with advanced or metastatic solid tumors.<\/p>\n<p>On July 13, 2020, NextCure made a shocking admission. Specifically, in a press release entitled, \u201cNextCure provides an Interim update of the Phase 2 Portion of the NC318 Monotherapy Phase 1\/2 Trial and Announces Departure Chief Medical Officer,\u201d NextCure announced that the Company was no longer planning to \u201cadvance the nonsmall cell lung cancer (NSCLC) and ovarian cancer cohorts in the stage 2 portion of the Simon 2-stage trial,\u201d citing \u201cclinical response data\u201d and \u201ccurrent enrollment criteria.\u201d The July 13, 2020 announcement continued, stating, in relevant part, \u201cThe analysis of biomarker data for these cohorts has been delayed and is not yet complete. The company will evaluate whether to pursue additional monotherapy studies in NSCLC and ovarian cancer after a review of that information.&#8221;<\/p>\n<p>On this news, NextCure&#8217;s shares, which had closed at $17.88 per share on July 10, 2020, dropped over 54% the next trading day to close at $8.15 per share on July 13, 2020 on unusually high trading volume.<\/p>\n<p>If you wish to serve as lead plaintiff, you must move the Court no later than November 20, 2020. A lead plaintiff is a representative party acting on behalf of other class members in directing the litigation. Your ability to share in any recovery doesn\u2019t require that you serve as lead plaintiff. If you choose to take no action, you may remain an absent class member.<\/p>\n<p>If you <strong>purchased<\/strong><strong>NextCure<\/strong><strong>securities, and\/or would like to discuss your legal rights and options<\/strong> please visit <a href=\"https:\/\/www.globenewswire.com\/Tracker?data=I7LMAVfsV_xtvAXmSZhF0xGI3_DeOYW0KslKns8-lQ7ms-7lVIV5Q2COdKUyRoEuLMRsMAKqPpKPKEtmO1o_GSnTM3j-CU6UejVlosYLydKWBTRF2X_4EcFvFW-kM3Mqlx4FPDB57_WwyINP5Z2aoT8Ebix_t6RR96rP4hkXQn-Xoddu0e-nYxjzuzUsFWZCgJYXsKCaym1X7i14zE5E4cftMW1XPjHaxWbepdPgp3ssPYJbDSGJSa_rhEANlhNbe7Ja4Peqf5nNXWab6N6btA==\" rel=\"nofollow noopener noreferrer\" target=\"_blank\">https:\/\/www.bernlieb.com\/cases\/nextcureinc-nxtc-shareholder-class-action-<\/a><a href=\"https:\/\/www.globenewswire.com\/Tracker?data=6b2C0J32iO6NK9p4pxcVPVawOCBoB5q2Al_U0AP_YVgoglqf0Yrr5YPheKwA5hZht1mKZUOpJQwjfzJW7zD1t8M6glEy-vHyBOdWH124P4ThLZq3VA55rq22pVe9YlQopoIcJDFfntES3oC_H07jQkT-fjKOpSUUm_UbRFQnuYBvYtHFxzFPbXaC0BWwyrBn2oms4ZRyaLyIGddTLD-p0Q==\" rel=\"nofollow noopener noreferrer\" target=\"_blank\">lawsuit-stock-fraud-313\/apply\/<\/a> contact <a href=\"https:\/\/www.globenewswire.com\/Tracker?data=QE4xSYFeDqWAbaLeuAJ8eIo18mLvV-EztHtIsE2PdlD36-gHk4GMQJIGK8EpEtYz1JIHcHkkKE7EWnYCtKw9tc6aTYKOsWwlyChT5OaruQ4=\" rel=\"nofollow noopener noreferrer\" target=\"_blank\">Matthew E. Guarnero<\/a> toll free at <strong>(877) 779-1414<\/strong> or <a href=\"https:\/\/www.globenewswire.com\/Tracker?data=U3XY2jaO9rXoljJphjpATGMjKzccvKxPp-9Gm8RcD_hn_ag2PNGIM5c4bZWpnn0KjCcp6hqXh8IHkQDqgWVtGtVkD0EDLgDJeCSQvDqpWIY=\" rel=\"nofollow noopener noreferrer\" target=\"_blank\">MGuarnero@bernlieb.com<\/a>.<\/p>\n<p>Since 1993, Bernstein Liebhard LLP has recovered over $3.5 billion for its clients. In addition to representing individual investors, the Firm has been retained by some of the largest public and private pension funds in the country to monitor their assets and pursue litigation on their behalf. As a result of its success litigating hundreds of lawsuits and class actions, the Firm has been named to\u00a0The National Law Journal\u2019s\u00a0\u201cPlaintiffs\u2019 Hot List\u201d thirteen times and listed in\u00a0The Legal 500\u00a0for ten consecutive years.<\/p>\n<p>ATTORNEY ADVERTISING. \u00a9 2020 Bernstein Liebhard LLP. The law firm responsible for this advertisement is Bernstein Liebhard LLP, 10 East 40th Street, New York, New York 10016, (212) 779-1414. The lawyer responsible for this advertisement in the State of Connecticut is Michael S. Bigin.\u00a0 Prior results do not guarantee or predict a similar outcome with respect to any future matter.<\/p>\n<p>Contact Information<br \/><a href=\"https:\/\/www.globenewswire.com\/Tracker?data=QE4xSYFeDqWAbaLeuAJ8ePEeKoA7jumUiTJszUIY3W95C805NGUl7D2nqL_NIcjmE3aZ451wDDRETYMTrAgAUShKUfy08S8V6S4aFtLCtkU=\" rel=\"nofollow noopener noreferrer\" target=\"_blank\">Matthew E. Guarnero<\/a><br \/>Bernstein Liebhard LLP<br \/><a href=\"https:\/\/www.globenewswire.com\/Tracker?data=I7LMAVfsV_xtvAXmSZhF0xGI3_DeOYW0KslKns8-lQ5FfMIwfbN9EZOn5r8uwPtHm1JFw8vZLE1YqWU0Ar7eOOgwopBVo7IX4L4OJcIpSWE=\" rel=\"nofollow noopener noreferrer\" target=\"_blank\">https:\/\/www.bernlieb.com<\/a><br \/>(877) 779-1414<br \/><a href=\"https:\/\/www.globenewswire.com\/Tracker?data=U3XY2jaO9rXoljJphjpATGMjKzccvKxPp-9Gm8RcD_hMcsmFBVgJxW9wXLABtdIk13K3p4PLDNWqjdL7DjKdGqzM10GR6m0pgm9jIHg-8w4=\" rel=\"nofollow noopener noreferrer\" target=\"_blank\">MGuarnero@bernlieb.com<\/a><\/p>\n<p \/>\n      <img loading=\"lazy\" decoding=\"async\" class=\"__GNW8366DE3E__IMG\" src=\"https:\/\/www.globenewswire.com\/newsroom\/ti?nf=ODA4MzQxNCMzODE5OTA1IzIwMjkzNDk=\" width=\"1\" height=\"1\" \/>\n    <\/div>\n<div class=\"mw_contactinfo\"><\/div>\n","protected":false},"excerpt":{"rendered":"<p>NEW YORK, Nov. 18, 2020 (GLOBE NEWSWIRE) &#8212; Bernstein Liebhard, a nationally acclaimed investor rights law firm, reminds investors of the deadline to file a lead plaintiff motion in a securities class action that has been filed on behalf of investors that: (i) purchased or acquired the securities of NextCure, Inc. (\u201cNextCure\u201d or the \u201cCompany\u201d) (NASDAQ: NXTC) securities between November 5, 2019 to July 14, 2020; and (ii) purchased or acquired NextCure common stock pursuant to or traceable to the Company&#8217;s Registration Statement on Form S-1 which was filed with and declared effective by the SEC on November 12, and November 14, 2019. The lawsuit filed in the United States District Court for the Southern District of New York alleges &hellip; <\/p>\n<p class=\"link-more\"><a href=\"https:\/\/www.marketnewsdesk.com\/index.php\/nxtc-investor-filing-deadline-bernstein-liebhard-reminds-investors-of-the-deadline-to-file-a-lead-plaintiff-motion-in-a-securities-class-action-lawsuit-against-nextcure-inc-7\/\" class=\"more-link\">Continue reading<span class=\"screen-reader-text\"> &#8220;NXTC INVESTOR FILING DEADLINE: Bernstein Liebhard Reminds Investors of the Deadline to File a Lead Plaintiff Motion in a Securities Class Action Lawsuit Against NextCure Inc.&#8221;<\/span><\/a><\/p>\n","protected":false},"author":2,"featured_media":0,"comment_status":"closed","ping_status":"closed","sticky":false,"template":"","format":"standard","meta":{"footnotes":""},"categories":[],"tags":[],"class_list":["post-384229","post","type-post","status-publish","format-standard","hentry"],"yoast_head":"<!-- This site is optimized with the Yoast SEO plugin v27.7 - https:\/\/yoast.com\/product\/yoast-seo-wordpress\/ -->\n<title>NXTC INVESTOR FILING DEADLINE: Bernstein Liebhard Reminds Investors of the Deadline to File a Lead Plaintiff Motion in a Securities Class Action Lawsuit Against NextCure Inc. - Market Newsdesk<\/title>\n<meta name=\"robots\" content=\"index, follow, max-snippet:-1, max-image-preview:large, max-video-preview:-1\" \/>\n<link rel=\"canonical\" href=\"https:\/\/www.marketnewsdesk.com\/index.php\/nxtc-investor-filing-deadline-bernstein-liebhard-reminds-investors-of-the-deadline-to-file-a-lead-plaintiff-motion-in-a-securities-class-action-lawsuit-against-nextcure-inc-7\/\" \/>\n<meta property=\"og:locale\" content=\"en_US\" \/>\n<meta property=\"og:type\" content=\"article\" \/>\n<meta property=\"og:title\" content=\"NXTC INVESTOR FILING DEADLINE: Bernstein Liebhard Reminds Investors of the Deadline to File a Lead Plaintiff Motion in a Securities Class Action Lawsuit Against NextCure Inc. - Market Newsdesk\" \/>\n<meta property=\"og:description\" content=\"NEW YORK, Nov. 18, 2020 (GLOBE NEWSWIRE) &#8212; Bernstein Liebhard, a nationally acclaimed investor rights law firm, reminds investors of the deadline to file a lead plaintiff motion in a securities class action that has been filed on behalf of investors that: (i) purchased or acquired the securities of NextCure, Inc. (\u201cNextCure\u201d or the \u201cCompany\u201d) (NASDAQ: NXTC) securities between November 5, 2019 to July 14, 2020; and (ii) purchased or acquired NextCure common stock pursuant to or traceable to the Company&#8217;s Registration Statement on Form S-1 which was filed with and declared effective by the SEC on November 12, and November 14, 2019. The lawsuit filed in the United States District Court for the Southern District of New York alleges &hellip; Continue reading &quot;NXTC INVESTOR FILING DEADLINE: Bernstein Liebhard Reminds Investors of the Deadline to File a Lead Plaintiff Motion in a Securities Class Action Lawsuit Against NextCure Inc.&quot;\" \/>\n<meta property=\"og:url\" content=\"https:\/\/www.marketnewsdesk.com\/index.php\/nxtc-investor-filing-deadline-bernstein-liebhard-reminds-investors-of-the-deadline-to-file-a-lead-plaintiff-motion-in-a-securities-class-action-lawsuit-against-nextcure-inc-7\/\" \/>\n<meta property=\"og:site_name\" content=\"Market Newsdesk\" \/>\n<meta property=\"article:published_time\" content=\"2020-11-18T16:09:15+00:00\" \/>\n<meta property=\"og:image\" content=\"https:\/\/www.globenewswire.com\/newsroom\/ti?nf=ODA4MzQxNCMzODE5OTA1IzIwMjkzNDk=\" \/>\n<meta name=\"author\" content=\"Newsdesk\" \/>\n<meta name=\"twitter:card\" content=\"summary_large_image\" \/>\n<meta name=\"twitter:label1\" content=\"Written by\" \/>\n\t<meta name=\"twitter:data1\" content=\"Newsdesk\" \/>\n\t<meta name=\"twitter:label2\" content=\"Est. reading time\" \/>\n\t<meta name=\"twitter:data2\" content=\"3 minutes\" \/>\n<script type=\"application\/ld+json\" class=\"yoast-schema-graph\">{\"@context\":\"https:\\\/\\\/schema.org\",\"@graph\":[{\"@type\":\"Article\",\"@id\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/index.php\\\/nxtc-investor-filing-deadline-bernstein-liebhard-reminds-investors-of-the-deadline-to-file-a-lead-plaintiff-motion-in-a-securities-class-action-lawsuit-against-nextcure-inc-7\\\/#article\",\"isPartOf\":{\"@id\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/index.php\\\/nxtc-investor-filing-deadline-bernstein-liebhard-reminds-investors-of-the-deadline-to-file-a-lead-plaintiff-motion-in-a-securities-class-action-lawsuit-against-nextcure-inc-7\\\/\"},\"author\":{\"name\":\"Newsdesk\",\"@id\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/#\\\/schema\\\/person\\\/482f27a394d4fda80ecb5499e519d979\"},\"headline\":\"NXTC INVESTOR FILING DEADLINE: Bernstein Liebhard Reminds Investors of the Deadline to File a Lead Plaintiff Motion in a Securities Class Action Lawsuit Against NextCure Inc.\",\"datePublished\":\"2020-11-18T16:09:15+00:00\",\"mainEntityOfPage\":{\"@id\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/index.php\\\/nxtc-investor-filing-deadline-bernstein-liebhard-reminds-investors-of-the-deadline-to-file-a-lead-plaintiff-motion-in-a-securities-class-action-lawsuit-against-nextcure-inc-7\\\/\"},\"wordCount\":626,\"image\":{\"@id\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/index.php\\\/nxtc-investor-filing-deadline-bernstein-liebhard-reminds-investors-of-the-deadline-to-file-a-lead-plaintiff-motion-in-a-securities-class-action-lawsuit-against-nextcure-inc-7\\\/#primaryimage\"},\"thumbnailUrl\":\"https:\\\/\\\/www.globenewswire.com\\\/newsroom\\\/ti?nf=ODA4MzQxNCMzODE5OTA1IzIwMjkzNDk=\",\"inLanguage\":\"en-US\"},{\"@type\":\"WebPage\",\"@id\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/index.php\\\/nxtc-investor-filing-deadline-bernstein-liebhard-reminds-investors-of-the-deadline-to-file-a-lead-plaintiff-motion-in-a-securities-class-action-lawsuit-against-nextcure-inc-7\\\/\",\"url\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/index.php\\\/nxtc-investor-filing-deadline-bernstein-liebhard-reminds-investors-of-the-deadline-to-file-a-lead-plaintiff-motion-in-a-securities-class-action-lawsuit-against-nextcure-inc-7\\\/\",\"name\":\"NXTC INVESTOR FILING DEADLINE: Bernstein Liebhard Reminds Investors of the Deadline to File a Lead Plaintiff Motion in a Securities Class Action Lawsuit Against NextCure Inc. - Market Newsdesk\",\"isPartOf\":{\"@id\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/#website\"},\"primaryImageOfPage\":{\"@id\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/index.php\\\/nxtc-investor-filing-deadline-bernstein-liebhard-reminds-investors-of-the-deadline-to-file-a-lead-plaintiff-motion-in-a-securities-class-action-lawsuit-against-nextcure-inc-7\\\/#primaryimage\"},\"image\":{\"@id\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/index.php\\\/nxtc-investor-filing-deadline-bernstein-liebhard-reminds-investors-of-the-deadline-to-file-a-lead-plaintiff-motion-in-a-securities-class-action-lawsuit-against-nextcure-inc-7\\\/#primaryimage\"},\"thumbnailUrl\":\"https:\\\/\\\/www.globenewswire.com\\\/newsroom\\\/ti?nf=ODA4MzQxNCMzODE5OTA1IzIwMjkzNDk=\",\"datePublished\":\"2020-11-18T16:09:15+00:00\",\"author\":{\"@id\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/#\\\/schema\\\/person\\\/482f27a394d4fda80ecb5499e519d979\"},\"breadcrumb\":{\"@id\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/index.php\\\/nxtc-investor-filing-deadline-bernstein-liebhard-reminds-investors-of-the-deadline-to-file-a-lead-plaintiff-motion-in-a-securities-class-action-lawsuit-against-nextcure-inc-7\\\/#breadcrumb\"},\"inLanguage\":\"en-US\",\"potentialAction\":[{\"@type\":\"ReadAction\",\"target\":[\"https:\\\/\\\/www.marketnewsdesk.com\\\/index.php\\\/nxtc-investor-filing-deadline-bernstein-liebhard-reminds-investors-of-the-deadline-to-file-a-lead-plaintiff-motion-in-a-securities-class-action-lawsuit-against-nextcure-inc-7\\\/\"]}]},{\"@type\":\"ImageObject\",\"inLanguage\":\"en-US\",\"@id\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/index.php\\\/nxtc-investor-filing-deadline-bernstein-liebhard-reminds-investors-of-the-deadline-to-file-a-lead-plaintiff-motion-in-a-securities-class-action-lawsuit-against-nextcure-inc-7\\\/#primaryimage\",\"url\":\"https:\\\/\\\/www.globenewswire.com\\\/newsroom\\\/ti?nf=ODA4MzQxNCMzODE5OTA1IzIwMjkzNDk=\",\"contentUrl\":\"https:\\\/\\\/www.globenewswire.com\\\/newsroom\\\/ti?nf=ODA4MzQxNCMzODE5OTA1IzIwMjkzNDk=\"},{\"@type\":\"BreadcrumbList\",\"@id\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/index.php\\\/nxtc-investor-filing-deadline-bernstein-liebhard-reminds-investors-of-the-deadline-to-file-a-lead-plaintiff-motion-in-a-securities-class-action-lawsuit-against-nextcure-inc-7\\\/#breadcrumb\",\"itemListElement\":[{\"@type\":\"ListItem\",\"position\":1,\"name\":\"Home\",\"item\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/\"},{\"@type\":\"ListItem\",\"position\":2,\"name\":\"NXTC INVESTOR FILING DEADLINE: Bernstein Liebhard Reminds Investors of the Deadline to File a Lead Plaintiff Motion in a Securities Class Action Lawsuit Against NextCure Inc.\"}]},{\"@type\":\"WebSite\",\"@id\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/#website\",\"url\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/\",\"name\":\"Market Newsdesk\",\"description\":\"Latest Business News in Real Time\",\"potentialAction\":[{\"@type\":\"SearchAction\",\"target\":{\"@type\":\"EntryPoint\",\"urlTemplate\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/?s={search_term_string}\"},\"query-input\":{\"@type\":\"PropertyValueSpecification\",\"valueRequired\":true,\"valueName\":\"search_term_string\"}}],\"inLanguage\":\"en-US\"},{\"@type\":\"Person\",\"@id\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/#\\\/schema\\\/person\\\/482f27a394d4fda80ecb5499e519d979\",\"name\":\"Newsdesk\",\"image\":{\"@type\":\"ImageObject\",\"inLanguage\":\"en-US\",\"@id\":\"https:\\\/\\\/secure.gravatar.com\\\/avatar\\\/a0d0bd5b0f0ca12a265a459b13169dac35f33776d8501eda5e68844a366f2f46?s=96&d=mm&r=g\",\"url\":\"https:\\\/\\\/secure.gravatar.com\\\/avatar\\\/a0d0bd5b0f0ca12a265a459b13169dac35f33776d8501eda5e68844a366f2f46?s=96&d=mm&r=g\",\"contentUrl\":\"https:\\\/\\\/secure.gravatar.com\\\/avatar\\\/a0d0bd5b0f0ca12a265a459b13169dac35f33776d8501eda5e68844a366f2f46?s=96&d=mm&r=g\",\"caption\":\"Newsdesk\"},\"url\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/index.php\\\/author\\\/newsdesk\\\/\"}]}<\/script>\n<!-- \/ Yoast SEO plugin. -->","yoast_head_json":{"title":"NXTC INVESTOR FILING DEADLINE: Bernstein Liebhard Reminds Investors of the Deadline to File a Lead Plaintiff Motion in a Securities Class Action Lawsuit Against NextCure Inc. - Market Newsdesk","robots":{"index":"index","follow":"follow","max-snippet":"max-snippet:-1","max-image-preview":"max-image-preview:large","max-video-preview":"max-video-preview:-1"},"canonical":"https:\/\/www.marketnewsdesk.com\/index.php\/nxtc-investor-filing-deadline-bernstein-liebhard-reminds-investors-of-the-deadline-to-file-a-lead-plaintiff-motion-in-a-securities-class-action-lawsuit-against-nextcure-inc-7\/","og_locale":"en_US","og_type":"article","og_title":"NXTC INVESTOR FILING DEADLINE: Bernstein Liebhard Reminds Investors of the Deadline to File a Lead Plaintiff Motion in a Securities Class Action Lawsuit Against NextCure Inc. - Market Newsdesk","og_description":"NEW YORK, Nov. 18, 2020 (GLOBE NEWSWIRE) &#8212; Bernstein Liebhard, a nationally acclaimed investor rights law firm, reminds investors of the deadline to file a lead plaintiff motion in a securities class action that has been filed on behalf of investors that: (i) purchased or acquired the securities of NextCure, Inc. (\u201cNextCure\u201d or the \u201cCompany\u201d) (NASDAQ: NXTC) securities between November 5, 2019 to July 14, 2020; and (ii) purchased or acquired NextCure common stock pursuant to or traceable to the Company&#8217;s Registration Statement on Form S-1 which was filed with and declared effective by the SEC on November 12, and November 14, 2019. The lawsuit filed in the United States District Court for the Southern District of New York alleges &hellip; Continue reading \"NXTC INVESTOR FILING DEADLINE: Bernstein Liebhard Reminds Investors of the Deadline to File a Lead Plaintiff Motion in a Securities Class Action Lawsuit Against NextCure Inc.\"","og_url":"https:\/\/www.marketnewsdesk.com\/index.php\/nxtc-investor-filing-deadline-bernstein-liebhard-reminds-investors-of-the-deadline-to-file-a-lead-plaintiff-motion-in-a-securities-class-action-lawsuit-against-nextcure-inc-7\/","og_site_name":"Market Newsdesk","article_published_time":"2020-11-18T16:09:15+00:00","og_image":[{"url":"https:\/\/www.globenewswire.com\/newsroom\/ti?nf=ODA4MzQxNCMzODE5OTA1IzIwMjkzNDk=","type":"","width":"","height":""}],"author":"Newsdesk","twitter_card":"summary_large_image","twitter_misc":{"Written by":"Newsdesk","Est. reading time":"3 minutes"},"schema":{"@context":"https:\/\/schema.org","@graph":[{"@type":"Article","@id":"https:\/\/www.marketnewsdesk.com\/index.php\/nxtc-investor-filing-deadline-bernstein-liebhard-reminds-investors-of-the-deadline-to-file-a-lead-plaintiff-motion-in-a-securities-class-action-lawsuit-against-nextcure-inc-7\/#article","isPartOf":{"@id":"https:\/\/www.marketnewsdesk.com\/index.php\/nxtc-investor-filing-deadline-bernstein-liebhard-reminds-investors-of-the-deadline-to-file-a-lead-plaintiff-motion-in-a-securities-class-action-lawsuit-against-nextcure-inc-7\/"},"author":{"name":"Newsdesk","@id":"https:\/\/www.marketnewsdesk.com\/#\/schema\/person\/482f27a394d4fda80ecb5499e519d979"},"headline":"NXTC INVESTOR FILING DEADLINE: Bernstein Liebhard Reminds Investors of the Deadline to File a Lead Plaintiff Motion in a Securities Class Action Lawsuit Against NextCure Inc.","datePublished":"2020-11-18T16:09:15+00:00","mainEntityOfPage":{"@id":"https:\/\/www.marketnewsdesk.com\/index.php\/nxtc-investor-filing-deadline-bernstein-liebhard-reminds-investors-of-the-deadline-to-file-a-lead-plaintiff-motion-in-a-securities-class-action-lawsuit-against-nextcure-inc-7\/"},"wordCount":626,"image":{"@id":"https:\/\/www.marketnewsdesk.com\/index.php\/nxtc-investor-filing-deadline-bernstein-liebhard-reminds-investors-of-the-deadline-to-file-a-lead-plaintiff-motion-in-a-securities-class-action-lawsuit-against-nextcure-inc-7\/#primaryimage"},"thumbnailUrl":"https:\/\/www.globenewswire.com\/newsroom\/ti?nf=ODA4MzQxNCMzODE5OTA1IzIwMjkzNDk=","inLanguage":"en-US"},{"@type":"WebPage","@id":"https:\/\/www.marketnewsdesk.com\/index.php\/nxtc-investor-filing-deadline-bernstein-liebhard-reminds-investors-of-the-deadline-to-file-a-lead-plaintiff-motion-in-a-securities-class-action-lawsuit-against-nextcure-inc-7\/","url":"https:\/\/www.marketnewsdesk.com\/index.php\/nxtc-investor-filing-deadline-bernstein-liebhard-reminds-investors-of-the-deadline-to-file-a-lead-plaintiff-motion-in-a-securities-class-action-lawsuit-against-nextcure-inc-7\/","name":"NXTC INVESTOR FILING DEADLINE: Bernstein Liebhard Reminds Investors of the Deadline to File a Lead Plaintiff Motion in a Securities Class Action Lawsuit Against NextCure Inc. - Market Newsdesk","isPartOf":{"@id":"https:\/\/www.marketnewsdesk.com\/#website"},"primaryImageOfPage":{"@id":"https:\/\/www.marketnewsdesk.com\/index.php\/nxtc-investor-filing-deadline-bernstein-liebhard-reminds-investors-of-the-deadline-to-file-a-lead-plaintiff-motion-in-a-securities-class-action-lawsuit-against-nextcure-inc-7\/#primaryimage"},"image":{"@id":"https:\/\/www.marketnewsdesk.com\/index.php\/nxtc-investor-filing-deadline-bernstein-liebhard-reminds-investors-of-the-deadline-to-file-a-lead-plaintiff-motion-in-a-securities-class-action-lawsuit-against-nextcure-inc-7\/#primaryimage"},"thumbnailUrl":"https:\/\/www.globenewswire.com\/newsroom\/ti?nf=ODA4MzQxNCMzODE5OTA1IzIwMjkzNDk=","datePublished":"2020-11-18T16:09:15+00:00","author":{"@id":"https:\/\/www.marketnewsdesk.com\/#\/schema\/person\/482f27a394d4fda80ecb5499e519d979"},"breadcrumb":{"@id":"https:\/\/www.marketnewsdesk.com\/index.php\/nxtc-investor-filing-deadline-bernstein-liebhard-reminds-investors-of-the-deadline-to-file-a-lead-plaintiff-motion-in-a-securities-class-action-lawsuit-against-nextcure-inc-7\/#breadcrumb"},"inLanguage":"en-US","potentialAction":[{"@type":"ReadAction","target":["https:\/\/www.marketnewsdesk.com\/index.php\/nxtc-investor-filing-deadline-bernstein-liebhard-reminds-investors-of-the-deadline-to-file-a-lead-plaintiff-motion-in-a-securities-class-action-lawsuit-against-nextcure-inc-7\/"]}]},{"@type":"ImageObject","inLanguage":"en-US","@id":"https:\/\/www.marketnewsdesk.com\/index.php\/nxtc-investor-filing-deadline-bernstein-liebhard-reminds-investors-of-the-deadline-to-file-a-lead-plaintiff-motion-in-a-securities-class-action-lawsuit-against-nextcure-inc-7\/#primaryimage","url":"https:\/\/www.globenewswire.com\/newsroom\/ti?nf=ODA4MzQxNCMzODE5OTA1IzIwMjkzNDk=","contentUrl":"https:\/\/www.globenewswire.com\/newsroom\/ti?nf=ODA4MzQxNCMzODE5OTA1IzIwMjkzNDk="},{"@type":"BreadcrumbList","@id":"https:\/\/www.marketnewsdesk.com\/index.php\/nxtc-investor-filing-deadline-bernstein-liebhard-reminds-investors-of-the-deadline-to-file-a-lead-plaintiff-motion-in-a-securities-class-action-lawsuit-against-nextcure-inc-7\/#breadcrumb","itemListElement":[{"@type":"ListItem","position":1,"name":"Home","item":"https:\/\/www.marketnewsdesk.com\/"},{"@type":"ListItem","position":2,"name":"NXTC INVESTOR FILING DEADLINE: Bernstein Liebhard Reminds Investors of the Deadline to File a Lead Plaintiff Motion in a Securities Class Action Lawsuit Against NextCure Inc."}]},{"@type":"WebSite","@id":"https:\/\/www.marketnewsdesk.com\/#website","url":"https:\/\/www.marketnewsdesk.com\/","name":"Market Newsdesk","description":"Latest Business News in Real Time","potentialAction":[{"@type":"SearchAction","target":{"@type":"EntryPoint","urlTemplate":"https:\/\/www.marketnewsdesk.com\/?s={search_term_string}"},"query-input":{"@type":"PropertyValueSpecification","valueRequired":true,"valueName":"search_term_string"}}],"inLanguage":"en-US"},{"@type":"Person","@id":"https:\/\/www.marketnewsdesk.com\/#\/schema\/person\/482f27a394d4fda80ecb5499e519d979","name":"Newsdesk","image":{"@type":"ImageObject","inLanguage":"en-US","@id":"https:\/\/secure.gravatar.com\/avatar\/a0d0bd5b0f0ca12a265a459b13169dac35f33776d8501eda5e68844a366f2f46?s=96&d=mm&r=g","url":"https:\/\/secure.gravatar.com\/avatar\/a0d0bd5b0f0ca12a265a459b13169dac35f33776d8501eda5e68844a366f2f46?s=96&d=mm&r=g","contentUrl":"https:\/\/secure.gravatar.com\/avatar\/a0d0bd5b0f0ca12a265a459b13169dac35f33776d8501eda5e68844a366f2f46?s=96&d=mm&r=g","caption":"Newsdesk"},"url":"https:\/\/www.marketnewsdesk.com\/index.php\/author\/newsdesk\/"}]}},"_links":{"self":[{"href":"https:\/\/www.marketnewsdesk.com\/index.php\/wp-json\/wp\/v2\/posts\/384229","targetHints":{"allow":["GET"]}}],"collection":[{"href":"https:\/\/www.marketnewsdesk.com\/index.php\/wp-json\/wp\/v2\/posts"}],"about":[{"href":"https:\/\/www.marketnewsdesk.com\/index.php\/wp-json\/wp\/v2\/types\/post"}],"author":[{"embeddable":true,"href":"https:\/\/www.marketnewsdesk.com\/index.php\/wp-json\/wp\/v2\/users\/2"}],"replies":[{"embeddable":true,"href":"https:\/\/www.marketnewsdesk.com\/index.php\/wp-json\/wp\/v2\/comments?post=384229"}],"version-history":[{"count":0,"href":"https:\/\/www.marketnewsdesk.com\/index.php\/wp-json\/wp\/v2\/posts\/384229\/revisions"}],"wp:attachment":[{"href":"https:\/\/www.marketnewsdesk.com\/index.php\/wp-json\/wp\/v2\/media?parent=384229"}],"wp:term":[{"taxonomy":"category","embeddable":true,"href":"https:\/\/www.marketnewsdesk.com\/index.php\/wp-json\/wp\/v2\/categories?post=384229"},{"taxonomy":"post_tag","embeddable":true,"href":"https:\/\/www.marketnewsdesk.com\/index.php\/wp-json\/wp\/v2\/tags?post=384229"}],"curies":[{"name":"wp","href":"https:\/\/api.w.org\/{rel}","templated":true}]}}